LT5001
/ Lumosa Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 19, 2020
Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients
(clinicaltrials.gov)
- P1/2; N=78; Recruiting; Sponsor: Lumosa Therapeutics Co., Ltd.
Clinical • New P1/2 trial • Dermatology • Pruritus • Renal Disease
1 to 1
Of
1
Go to page
1